Waldemar Debinski to Cyclin-Dependent Kinase Inhibitor p16
This is a "connection" page, showing publications Waldemar Debinski has written about Cyclin-Dependent Kinase Inhibitor p16.
Su W, Hong L, Xu X, Huang S, Herpai D, Li L, Xu Y, Truong L, Hu WY, Wu X, Xiao C, Zhang W, Han J, Debinski W, Xiang R, Sun P. miR-30 disrupts senescence and promotes cancer by targeting both p16INK4A and DNA damage pathways. Oncogene. 2018 10; 37(42):5618-5632.